Clinical trial sites face a growing crisis: increasing complexity, staff shortages, and fragmented technology are creating major operational challenges. Over half of sites struggle to take on new trials, and 80% fail to meet enrollment targets on time. Meanwhile, drug development costs soar, with innovative medicines costing $1-2 billion to bring to market and 90% failing during clinical trials.

This Industry Pulse explores solutions to boost trial productivity through patient-centric approaches and site optimization. Experts discuss strategies to address site capacity issues, enhance patient experiences, and accelerate therapies to market. Explore:

• How site augmentation services can fill gaps in patient-facing and administrative roles, easing site burden
• Why AI-generated "digital twins" could save biopharma $20-30 billion annually by 2030
• Balancing experienced research centers with emerging sites to create a diverse, effective trial ecosystem